Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome

被引:44
作者
Azoulay, Elie [1 ]
Knoebl, Paul [2 ]
Garnacho-Montero, Jose [3 ]
Rusinova, Katerina [4 ]
Galstian, Gennadii [5 ]
Eggimann, Philippe [6 ]
Abroug, Fekri [7 ]
Benoit, Dominique [8 ]
von Bergwelt-Baildon, Michael [9 ]
Wendon, Julia [10 ]
Scully, Marie [11 ]
机构
[1] Hop St Louis, Med Intens Care Unit, Paris, France
[2] Med Univ Vienna, Vienna Gen Hosp, Vienna, Austria
[3] Virgen de Macarena Univ Hosp, Seville, Spain
[4] Charles Univ Prague, Fac Med 1, Univ Hosp, Prague, Czech Republic
[5] Natl Res Ctr Hematol, Moscow, Russia
[6] Univ Hosp Lausanne, Lausanne, Switzerland
[7] Fattouma Bourguiba Teaching Hosp Monastir, Monastir, Tunisia
[8] Ghent Univ Hosp, Ghent, Belgium
[9] Uniklin Cologne, Cologne, Germany
[10] Kings Coll Hosp London, London, England
[11] UCL, London, England
关键词
atypical hemolytic uremic syndrome; eculizumab; intensive care; organ failure; plasma exchange; thrombocytopenia; thrombotic microangiopathy; THROMBOTIC THROMBOCYTOPENIC PURPURA; COMPLEMENT INHIBITOR ECULIZUMAB; SYNDROME DIAGNOSIS; I TREAT; AHUS; MICROANGIOPATHIES; MANAGEMENT; ACTIVATION; MUTATIONS; INSIGHTS;
D O I
10.1016/j.chest.2017.03.055
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A typical hemolytic uremic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP) and other causes or conditions with thrombotic microangiopathy (TMA), such as disseminated intravascular coagulation or sepsis. Similarity in clinical presentation may hinder diagnosis and optimal treatment selection in the urgent setting in the ICU. However, there is currently no consensus on the diagnosis or treatment of aHUS for ICU specialists. This review aims to summarize available data on the diagnosis and treatment strategies of aHUS in the ICU to enhance the understanding of aHUS diagnosis and outcomes in patients managed in the ICU. To this end, a review of the recent literature (January 2009-March 2016) was performed to select the most relevant articles for ICU physicians. Based on the paucity of adult aHUS cases overall and within the ICU, no specific recommendations could be formally graded for the critical care setting. However, we recognize a core set of skills required by intensivists for diagnosing and managing patients with aHUS: recognizing thrombotic microangiopathies, differentiating aHUS from related conditions, recognizing involvement of other organ systems, understanding the pathophysiology of aHUS, knowing the diagnostic workup and relevant outcomes in critically ill patients with aHUS, and knowing the standard of care for patients with aHUS based on available data and guidelines. In conclusion, managing critically ill patients with aHUS requires basic skills that, in the absence of sufficient data from patients treated within the ICU, can be gleaned from an increasingly relevant literature outside the ICU. More data on critically ill patients with aHUS are needed to validate these conclusions within the ICU setting.
引用
收藏
页码:424 / 434
页数:11
相关论文
共 56 条
[11]   Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial [J].
Fakhouri, Fadi ;
Hourmant, Maryvonne ;
Campistol, Josep M. ;
Cataland, Spero R. ;
Espinosa, Mario ;
Gaber, A. Osama ;
Menne, Jan ;
Minetti, Enrico E. ;
Provot, Francois ;
Rondeau, Eric ;
Ruggenenti, Piero ;
Weekers, Laurent E. ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Legendre, Christophe M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (01) :84-93
[12]   Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases [J].
Fakhouri, Fadi ;
Delmas, Yahsou ;
Provot, Francois ;
Barbet, Christelle ;
Karras, Alexandre ;
Makdassi, Raifah ;
Courivaud, Cecile ;
Rifard, Khair ;
Servais, Aude ;
Allard, Catherine ;
Besson, Virginie ;
Cousin, Maud ;
Chatelet, Valerie ;
Goujon, Jean-Michel ;
Coindre, Jean-Philippe ;
Laurent, Guillaume ;
Loirat, Chantal ;
Fremeaux-Bacchi, Veronique .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (01) :40-48
[13]   Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome [J].
Feng, Shuju ;
Eyler, Stephen J. ;
Zhang, Yuzhou ;
Maga, Tara ;
Nester, Carla M. ;
Kroll, Michael H. ;
Smith, Richard J. ;
Afshar-Kharghan, Vahid .
BLOOD, 2013, 122 (08) :1487-1493
[14]   Atypical hemolytic uremic syndrome: from diagnosis to treatment [J].
Franchini, Massimo .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (11) :1679-1688
[15]   Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults [J].
Fremeaux-Bacchi, Veronique ;
Fakhouri, Fadi ;
Gamier, Arnaud ;
Bienaime, Frank ;
Dragon-Durey, Marie-Agnes ;
Ngo, Stephanie ;
Moulin, Bruno ;
Servais, Aude ;
Provot, Francois ;
Rostaing, Lionel ;
Burtey, Stephane ;
Niaudet, Patrick ;
Deschenes, Georges ;
Lebranchu, Yvon ;
Zuber, Julien ;
Loirat, Chantal .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (04) :554-562
[16]   Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome [J].
Fremeaux-Bacchi, Veronique ;
Miller, Elizabeth C. ;
Liszewski, M. Kathryn ;
Strain, Lisa ;
Blouin, Jacques ;
Brown, Alison L. ;
Moghal, Nadeem ;
Kaplan, Bernard S. ;
Weiss, Robert A. ;
Lhotta, Karl ;
Kapur, Gaurav ;
Mattoo, Tej ;
Nivet, Hubert ;
Wong, William ;
Gie, Sophie ;
de Ligny, Bruno Hurault ;
Fischbach, Michel ;
Gupta, Ritu ;
Hauhart, Richard ;
Meunier, Vincent ;
Loirat, Chantal ;
Dragon-Durey, Marie-Agnes ;
Fridman, Wolf H. ;
Janssen, Bert J. C. ;
Goodship, Timothy H. J. ;
Atkinson, John P. .
BLOOD, 2008, 112 (13) :4948-4952
[17]   Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome [J].
Greenbaum, Larry A. ;
Fila, Marc ;
Ardissino, Gianluigi ;
Al-Akash, Samhar I. ;
Evans, Jonathan ;
Henning, Paul ;
Lieberman, Kenneth V. ;
Maringhini, Silvio ;
Pape, Lars ;
Rees, Lesley ;
van de Kar, Nicole C. A. J. ;
Vande Walle, Johan ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Licht, Christoph .
KIDNEY INTERNATIONAL, 2016, 89 (03) :701-711
[18]  
Greenbaum Larry A, 2014, Adv Pediatr, V61, P335, DOI 10.1016/j.yapd.2014.04.001
[19]   Extra-renal manifestations of complement-mediated thrombotic microangiopathies [J].
Hofer, Johannes ;
Rosales, Alejandra ;
Fischer, Caroline ;
Giner, Thomas .
FRONTIERS IN PEDIATRICS, 2014, 2
[20]  
Hunt BJ, 2014, NEW ENGL J MED, V370, P2153, DOI [10.1056/NEJMc1403768, 10.1056/NEJMra1208626]